#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Colitis ulcerative Ductal adenocarcinoma of pancreas Primary myelofibrosis Anti-myelin-associated glycoprotein associated polyneuropathy Desmoid tumour Pustular psoriasis Extranodal marginal zone B-cell lymphoma (MALT type) B-cell small lymphocytic lymphoma refractory Extra-osseous Ewing's sarcoma metastatic Phenylketonuria Osteosarcoma recurrent Craniopharyngioma Anal fistula Type IIa hyperlipidaemia Bronchopulmonary aspergillosis More trials…

    Learn about Rare Diseases

    Acquired haemophilia – Basic Information Short-bowel syndrome – Basic Information Soft tissue sarcoma Mucopolysaccharidosis Proteus syndrome – Diagnostics Short-bowel syndrome – Trials in Disease Haemophagocytic lymphohistiocytosis – Diagnostics Hereditary ataxia – Trials in Disease Mast cell activation syndrome – Life with Disease Ehlers-Danlos syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cariprazine Hydrochloride Vesleteplirsen Tozinameran MB-CART2219.1 Ribonucleic Acid K30 Ag-946 Phosphate 12 Grass Pollen Mixture Iph6501 Calcium Polystyrene Sulfonate Oxazepam Vimseltinib Bdc-1001 Ontasameran Tiapride RUBIDIUM CHLORIDE Glycerol Colecalciferol Povidone Holcus Lanatus Pollen Extract Esk-001 More therapies…

    Learn about Your Condition

    Acute coronary syndrome Aneurysm ruptured Acute respiratory failure Organ donor Anaemia Acoustic neuroma Follicular lymphoma Cutaneous sarcoidosis Sleep disorder Kearns-Sayre syndrome Varicella Metastatic neoplasm BK virus infection Biopsy heart Uterine cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Dementia Alzheimer’s type

  • Study of trospium chloride and xanomeline tartrate (KarXT) in patients with psychosis associated with Alzheimer’s disease

    Recruiting

    3 1
    Investigated Diseases:
    • Psychotic disorder
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Belgium Bulgaria Croatia France Germany Greece +7

  • A study of SAR448851 with FLORQUINITAU (18F) to assess safety and effectiveness in early Alzheimer’s disease

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Florquinitau (18F)
    Spain

  • A Phase 2 Study of TML-6 in Adults with Early Alzheimer’s Disease to Evaluate Safety, Tolerability, and Efficacy

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Sweden

  • Phase 2 Randomized Study of Mivelsiran in Adults with Early-Stage Down Syndrome-Associated Alzheimer’s Disease

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • ALN-961583
    • Water For Injection
    Germany Ireland Italy The Netherlands Spain

  • A study to evaluate the safety and effectiveness of dextromethorphan, deramciclane fumarate, and deramciclane in treating agitation in people with Alzheimer’s disease

    Not yet recruiting

    4 1
    Investigated Diseases:
    • Agitation
    • Dementia Alzheimer’s type
    Czechia Germany Italy Poland Slovakia Spain

  • Study on Thiethylperazine and Florbetaben (18F) for Early Alzheimer’s Disease Patients

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Florbetaben (18F)
    Germany
Previous Page
1 … 5 6 7 8 9 … 15
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!